Ensitrelvir represents a significant advancement in the treatment of COVID-19, setting the stage for enhanced defenses ...

BEIJING--When Li’s 83-year-old father with diabetes started coughing and complaining of body aches last month, the Beijing ...

This is according to results from two national trials. With COVID-19 still causing significant illness and death, clinicians urgently need to know which patients benefit most from early antiviral ...

As concerns grow over a hantavirus outbreak traced back to an Antarctic cruise, Britain has taken swift action by securing ...

Glenmark Pharmaceuticals on Saturday said it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the ...

The 27th batch of the Chinese medical team to Sierra Leone on Friday donated a consignment of antiviral medications to Sierra Leone's Ministry of Health and Sanitation in Freetown, the country's ...

No antivirals are approved as postexposure prophylaxis for household contacts of people with COVID-19. In this randomized study, 2.9% of household contacts who took ensitrelvir developed COVID within ...

(NYSE American:NNVC, opens new tab) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot ...

The antiviral favipiravir, from the Japanese company Fujifilm, that gained fame during the COVID-19 pandemic, is being ...

Ensitrelvir, an oral SARS-CoV-2 3C-like protease inhibitor, reduced symptomatic RT-PCR-confirmed COVID-19 among household ...

Plus, when it will actually be available in the U.S.

A new drug candidate could help treat measles, croup and other related viral diseases that cause contagious and ...